Skip to main content
. Author manuscript; available in PMC: 2023 May 16.
Published in final edited form as: Acta Neuropathol. 2022 Sep 30;144(6):1127–1142. doi: 10.1007/s00401-022-02506-4

Fig. 2: Proteomic subtypes of GBM across disease states.

Fig. 2:

a, Proteomic subtypes were identified in 40 matched pGBM-rGBM pairs. Clinical covariates indicating tumour classification, age at treatment (years), transcriptomic subtype, sex and pathway enrichment for proteomic subtypes are shown. b, pGBM and rGBM samples from the same patient classify as different proteomic (n = 40; replicate pGBM or rGBM samples were removed for simplicity) and c, transcriptomic subtypes (n = 22).